Project Details
| Status | Active |
|---|---|
| Effective start/end date | 5/20/11 → 12/1/25 |
Funding
- National Comprehensive Cancer Network (Prot#NU 10H06 // Prot#NU 10H06)
- Novartis Pharmaceuticals Corporation (Prot#NU 10H06 // Prot#NU 10H06)
Prot#NU 10H06: Correlative Studies In Conjunction with A Phase 2 Trial of Alemtuzumab-Ofatumumab Combination In Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
- Ma, Shuo (PD/PI)
- Goolsby, Charles Lewis (Co-Investigator)
Project: Research project